With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging / Picano E.; Ciampi Q.; Cortigiani L.; Arruda-Olson A.M.; Borguezan-Daros C.; Pretto J.L.C.E.S.; Cocchia R.; Bossone E.; Merli E.; Kane G.C.; Varga A.; Agoston G.; Scali M.C.; Morrone D.; Simova I.; Samardjieva M.; Boshchenko A.; Ryabova T.; Vrublevsky A.; Palinkas A.; Palinkas E.D.; Sepp R.; Torres M.A.R.; Villarraga H.R.; Preradovic T.K.; Citro R.; Amor M.; Mosto H.; Salame M.; Leeson P.; Mangia C.; Gaibazzi N.; Tuttolomondo D.; Prota C.; Peteiro J.; Van De Heyning C.M.; D'Andrea A.; Rigo F.; Nikolic A.; Ostojic M.; Lowenstein J.; Arbucci R.; Lowenstein Haber D.M.; Merlo P.M.; Wierzbowska-Drabik K.; Kasprzak J.D.; Haberka M.; Camarozano A.C.; Ratanasit N.; Mori F.; D'Alfonso M.G.; Tassetti L.; Milazzo A.; Olivotto I.; Marchi A.; Rodriguez-Zanella H.; Zagatina A.; Padang R.; Dekleva M.; Djordievic-Dikic A.; Boskovic N.; Tesic M.; Giga V.; Beleslin B.; Di Salvo G.; Lorenzoni V.; Cameli M.; Mandoli G.E.; Bombardini T.; Caso P.; Celutkiene J.; Barbieri A.; Benfari G.; Bartolacelli Y.; Malagoli A.; Bursi F.; Mantovani F.; Villari B.; Russo A.; De Nes M.; Carpeggiani C.; Monte I.; Re F.; Cotrim C.; Bilardo G.; Saad A.K.; Karuzas A.; Matuliaskas D.; Colonna P.; Antonini-Canterin F.; Pepi M.; Pellikka P.A.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - ELETTRONICO. - 10:(2021), pp. 3641-3641. [10.3390/jcm10163641]
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging
Mori F.;D'Alfonso M. G.;Tassetti L.;Milazzo A.;Olivotto I.;Marchi A.;Mantovani F.;
2021
Abstract
With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.File | Dimensione | Formato | |
---|---|---|---|
jcm-10-03641-v2.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
786.5 kB
Formato
Adobe PDF
|
786.5 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.